TREACE MEDICAL CONCEPTS, INC. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Treace Medical Concepts, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Treace Medical Concepts, Inc. Return On Equity for the quarter ending September 30, 2024 was -51.1 %, a 35.7% decline year-over-year.
  • Treace Medical Concepts, Inc. annual Return On Equity for 2023 was -34 %, a 44.2% increase from 2022.
  • Treace Medical Concepts, Inc. annual Return On Equity for 2022 was -60.9 %, a 117% decline from 2021.
  • Treace Medical Concepts, Inc. annual Return On Equity for 2021 was -28.1 %, a 51.5% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -51.1 -13.5 -35.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -49.5 -10.2 -26% Apr 1, 2024 Jun 30, 2024
Q1 2024 -39.7 +14 +26.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -34 +26.9 +44.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -37.7 +19.7 +34.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -39.3 +5.76 +12.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -53.7 -25.1 -87.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -60.9 -32.8 -117% Oct 1, 2022 Dec 31, 2022
Q3 2022 -57.4 -34.7 -153% Jul 1, 2022 Sep 30, 2022
Q2 2022 -45.1 -14.8 -49% Apr 1, 2022 Jun 30, 2022
Q1 2022 -28.6 -5.12 -21.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -28.1 -9.55 -51.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -22.7 Jul 1, 2021 Sep 30, 2021
Q2 2021 -30.3 Apr 1, 2021 Jun 30, 2021
Q1 2021 -23.5 Jan 1, 2021 Mar 31, 2021
Q4 2020 -18.5 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.